Exact Sciences - Stock Price History | EXAS

Historical daily share price chart and data for Exact Sciences since 2019 adjusted for splits. The latest closing stock price for Exact Sciences as of October 16, 2019 is 97.58.
  • The all-time high Exact Sciences stock closing price was 122.49 on September 05, 2019.
  • The Exact Sciences 52-week high stock price is 123.99, which is 27.1% above the current share price.
  • The Exact Sciences 52-week low stock price is 53.06, which is 45.6% below the current share price.
  • The average Exact Sciences stock price for the last 52 weeks is 93.53.
Exact Sciences Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2018 59.1706 51.7900 82.6600 37.8400 63.1000 20.10%
2017 36.1470 13.4100 60.5100 13.4100 52.5400 293.26%
2016 11.9728 9.0000 21.4900 4.9400 13.3600 44.75%
2015 20.6162 26.7900 31.1600 7.1300 9.2300 -66.36%
2014 17.5492 11.8200 29.6500 11.1700 27.4400 133.53%
2013 11.5220 11.0500 14.4700 8.1400 11.7500 10.95%
2012 10.0498 8.0700 11.8900 7.9300 10.5900 30.42%
2011 7.2547 6.1800 9.2000 4.9700 8.1200 35.79%
2010 4.9898 3.4000 8.9200 3.3100 5.9800 76.40%
2009 2.0877 0.5800 3.3900 0.5800 3.3900 494.74%
2008 1.5940 3.3801 3.4700 0.3500 0.5700 -82.30%
2007 3.1721 2.7200 6.0200 2.3299 3.2200 13.78%
2006 2.3746 2.3200 4.2600 1.6300 2.8300 28.05%
2005 2.6917 3.7400 4.6500 1.3400 2.2100 -42.30%
2004 5.6878 10.1500 10.2500 2.4600 3.8300 -62.15%
2003 11.4631 11.5400 17.5500 6.5000 10.1200 -6.56%
2002 11.8529 10.2500 16.5800 7.9000 10.8300 5.56%
2001 9.3984 15.0000 15.1700 5.3000 10.2600 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $12.282B $0.454B
EXACT Sciences Corporation uses applied genomics to develop effective, patient-friendly screening technologies for use in the detection of cancer. Certain of its technologies have been licensed to Laboratory Corporation of America Holdings for a stool-based DNA screening assay for colorectal cancer in the average-risk population. Colorectal cancer, which is the most deadly cancer among non-smokers, is generally curable if detected early. Despite the availability of colorectal cancer screening and diagnostic tests for more than twenty years, the rate of early detection of colorectal cancer remains low, and deaths from colorectal cancer remain high. EXACT Sciences believes its genomics-based technologies would help to enable detection of colorectal cancer so that more people can be effectively treated.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $121.673B 13.86
Gilead Sciences (GILD) United States $81.699B 10.03
CSL (CSLLY) Australia $74.842B 0.00
Celgene (CELG) United States $71.151B 11.01
Illumina (ILMN) United States $45.616B 53.59
Vertex Pharmaceuticals (VRTX) United States $44.619B 48.22
Biogen (BIIB) United States $41.641B 7.40
Regeneron Pharmaceuticals (REGN) United States $33.547B 15.23
Actelion (ALIOF) Switzerland $29.891B 0.00
Alexion Pharmaceuticals (ALXN) United States $22.723B 11.98
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.152B 0.00
Incyte (INCY) United States $16.659B 49.03
Seattle Genetics (SGEN) United States $13.329B 0.00
Genmab (GNMSF) Denmark $12.097B 67.86
BioMarin Pharmaceutical (BMRN) United States $12.067B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.647B 51.72
Alnylam Pharmaceuticals (ALNY) United States $8.801B 0.00
Galapagos (GLPG) Belgium $8.558B 0.00
Bio-Techne Corp (TECH) United States $7.583B 52.38
Sarepta Therapeutics (SRPT) United States $6.371B 0.00
QIAGEN (QGEN) Netherlands $6.143B 20.18
Guardant Health (GH) United States $5.967B 0.00
BeiGene (BGNE) Cayman Islands $5.817B 0.00
ACADIA Pharmaceuticals (ACAD) United States $5.704B 0.00
Amarin (AMRN) Ireland $5.519B 0.00
Horizon Therapeutics Public (HZNP) Ireland $5.086B 12.93
Exelixis (EXEL) United States $4.962B 12.90
Bluebird Bio (BLUE) United States $4.907B 0.00
Moderna (MRNA) United States $4.599B 0.00
China Biologic Products (CBPO) China $4.526B 28.25
ARGENX SE-ADR (ARGX) Netherlands $4.253B 0.00
Medicines (MDCO) United States $4.141B 0.00
Ascendis Pharma (ASND) Denmark $3.986B 0.00
Repligen (RGEN) United States $3.981B 77.25
Spark Therapeutics (ONCE) United States $3.797B 0.00
Blueprint Medicines (BPMC) United States $3.534B 0.00
MorphoSys AG (MOR) Germany $3.402B 0.00
Reata Pharmaceuticals (RETA) United States $3.028B 0.00
Mirati Therapeutics (MRTX) United States $3.024B 0.00
Alkermes (ALKS) Ireland $2.810B 0.00
Emergent Biosolutions (EBS) United States $2.707B 40.67
Immunomedics (IMMU) United States $2.699B 0.00
Genomic Health (GHDX) United States $2.601B 48.78
Genmab (GMAB) Denmark $2.547B 0.00
MyoKardia (MYOK) United States $2.458B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.403B 0.00
Arena Pharmaceuticals (ARNA) United States $2.358B 5.07
Halozyme Therapeutics (HALO) United States $2.297B 0.00
RA PHARMCTL INC (RARX) United States $2.207B 0.00
Myriad Genetics (MYGN) United States $2.192B 23.01
Acceleron Pharma (XLRN) United States $2.121B 0.00
NeoGenomics (NEO) United States $2.046B 109.44
Amicus Therapeutics (FOLD) United States $2.022B 0.00
Cambrex (CBM) United States $2.010B 25.41
CRISPR Therapeutics AG (CRSP) Switzerland $2.005B 0.00
Ligand Pharmaceuticals (LGND) United States $1.991B 25.17
Intercept Pharmaceuticals (ICPT) United States $1.989B 0.00
Zai Lab (ZLAB) China $1.942B 0.00
Akcea Therapeutics (AKCA) United States $1.819B 0.00
Alder BioPharmaceuticals (ALDR) United States $1.586B 0.00
UniQure (QURE) Netherlands $1.586B 0.00
Insmed (INSM) United States $1.522B 0.00
Denali Therapeutics (DNLI) United States $1.437B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.401B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.326B 0.00
REGENXBIO (RGNX) United States $1.281B 0.00
Coherus BioSciences (CHRS) United States $1.255B 0.00
Zymeworks (ZYME) Canada $1.101B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.093B 0.00
Innoviva (INVA) United States $1.084B 3.13
Alector (ALEC) United States $1.010B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.003B 0.00
Editas Medicine (EDIT) United States $0.982B 0.00
Sangamo Therapeutics (SGMO) United States $0.929B 0.00
Fate Therapeutics (FATE) United States $0.924B 0.00
AnaptysBio (ANAB) United States $0.916B 0.00
Epizyme (EPZM) United States $0.911B 0.00
ANI Pharmaceuticals (ANIP) United States $0.860B 14.36
Athenex (ATNX) United States $0.837B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.805B 0.00
Anika Therapeutics (ANIK) United States $0.785B 27.78
Pharming Group (PHGUF) Netherlands $0.782B 0.00
Codexis (CDXS) United States $0.777B 0.00
Cara Therapeutics (CARA) United States $0.755B 0.00
Twist Bioscience (TWST) United States $0.746B 0.00
Zealand Pharma (ZEAL) Denmark $0.738B 8.28
Zealand Pharma (ZLDPF) Denmark $0.722B 0.00
Principia Biopharma (PRNB) United States $0.705B 364.63
ZIOPHARM Oncology Inc (ZIOP) United States $0.697B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.689B 24.89
WAVE Life Sciences (WVE) Singapore $0.681B 0.00
Cytokineticsorporated (CYTK) United States $0.654B 0.00
Vericel (VCEL) United States $0.636B 0.00
Mesoblast (MESO) Australia $0.620B 0.00
Revance Therapeutics (RVNC) United States $0.618B 0.00
Heska (HSKA) United States $0.570B 73.87
Arvinas (ARVN) United States $0.562B 0.00
GENFIT S.A (GNFT) France $0.550B 0.00
MiMedx (MDXG) United States $0.550B 0.00
Intellia Therapeutics (NTLA) United States $0.533B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.502B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.496B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.488B 0.00
PHARMA MAR SA (PHMMF) Spain $0.482B 0.00
Retrophin (RTRX) United States $0.478B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
UROGEN PHARMA (URGN) United States $0.443B 0.00
BioDelivery Sciences (BDSI) United States $0.430B 0.00
Intra-Cellular Therapies (ITCI) United States $0.429B 0.00
DBV Technologies S.A (DBVT) France $0.427B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.424B 0.00
Cellectis S.A (CLLS) France $0.413B 0.00
Adverum Biotechnologies (ADVM) United States $0.393B 0.00
Stemline Therapeutics (STML) United States $0.382B 0.00
Syros Pharmaceuticals (SYRS) United States $0.370B 0.00
Agenus (AGEN) United States $0.369B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.368B 0.00
Arcus Biosciences (RCUS) United States $0.367B 0.00
Bellus Health (BLU) Canada $0.366B 0.00
Merus (MRUS) Netherlands $0.361B 0.00
Precision BioSciences (DTIL) United States $0.349B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.344B 0.00
Kadmon Holdings (KDMN) United States $0.337B 0.00
AC Immune SA (ACIU) Switzerland $0.335B 24.80
CytomX Therapeutics (CTMX) United States $0.320B 0.00
Prothena (PRTA) Ireland $0.311B 0.00
Gritstone Oncology (GRTS) United States $0.307B 0.00
Protagonist Therapeutics (PTGX) United States $0.300B 0.00
Avid Bioservices (CDMO) United States $0.298B 0.00
Theratechnologies (THTX) Canada $0.291B 0.00
Cellular Biomedicine (CBMG) United States $0.285B 0.00
Pfenex (PFNX) United States $0.283B 0.00
Starpharma Holdings (SPHRY) Australia $0.279B 0.00
Geron (GERN) United States $0.275B 0.00
Cel-Sci (CVM) United States $0.275B 0.00
Kindred Biosciences (KIN) United States $0.273B 0.00
PDL BioPharma (PDLI) United States $0.273B 7.03
Scholar Rock Holding (SRRK) United States $0.269B 0.00
Dynavax Technologies (DVAX) United States $0.266B 0.00
Biofrontera AG (BFRA) Germany $0.265B 395.33
Puma Biotechnology (PBYI) United States $0.264B 0.00
MannKind (MNKD) United States $0.245B 0.00
Prometic Life Sciences (PFSCF) Canada $0.235B 0.00
ADMA Biologics Inc (ADMA) United States $0.232B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.230B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.217B 0.00
Sutro Biopharma (STRO) United States $0.216B 0.00
Albireo Pharma (ALBO) United States $0.215B 0.00
Seres Therapeutics (MCRB) United States $0.214B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.213B 0.00
OSMOTICA PHARM (OSMT) United States $0.212B 0.00
Inovio Pharmaceuticals (INO) United States $0.211B 0.00
Compugen (CGEN) Israel $0.206B 0.00
Sorrento Therapeutics (SRNE) United States $0.206B 0.00
Athersys (ATHX) United States $0.205B 0.00
Exicure (XCUR) United States $0.204B 0.00
POXEL SA FRANCE (PXXLF) France $0.204B 0.00
Kamada (KMDA) Israel $0.203B 7.77
Spero Therapeutics (SPRO) United States $0.202B 0.00
Palatin Technologies (PTN) United States $0.186B 5.45
ChromaDex (CDXC) United States $0.182B 0.00
Nicox SA (NICXF) France $0.175B 0.00
Dyadic (DYAI) United States $0.173B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.173B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.172B 0.00
Clovis Oncology (CLVS) United States $0.171B 0.00
Affimed (AFMD) Germany $0.167B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.165B 0.00
Cue Biopharma (CUE) United States $0.159B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.159B 0.00
Enzo Biochem (ENZ) United States $0.158B 0.00
XOMA (XOMA) United States $0.156B 0.00
Alcobra (ARCT) United States $0.151B 0.00
Senesco Technologies (ELOX) United States $0.151B 0.00
Cerecor (CERC) United States $0.151B 0.00
Five Prime Therapeutics (FPRX) United States $0.150B 0.00
Arsanis (XFOR) United States $0.144B 0.00
BioTime (LCTX) United States $0.139B 9.30
Northwest Biotherapeutics (NWBO) United States $0.136B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.133B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.129B 0.00
CorMedix Inc (CRMD) United States $0.126B 0.00
NantKwest (NK) United States $0.118B 0.00
SESEN BIO, INC (SESN) United States $0.117B 0.00
Acorda Therapeutics (ACOR) United States $0.115B 0.00
PHASEBIO PHARMA (PHAS) United States $0.113B 0.00
Windtree Therapeutics (WINT) United States $0.113B 0.00
Novavax (NVAX) United States $0.112B 0.00
Menlo Therapeutics (MNLO) United States $0.109B 0.00
Strongbridge Biopharma (SBBP) United States $0.107B 4.40
Abeona Therapeutics (ABEO) United States $0.107B 0.00
Emmaus Life Sciences (EMMA) United States $0.107B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.107B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.104B 0.00
Celyad SA (CYAD) Belgium $0.098B 0.00
Aptinyx (APTX) United States $0.095B 0.00
OvaScience (MLND) United States $0.095B 0.00
Trevena (TRVN) United States $0.091B 0.00
VBI Vaccines (VBIV) United States $0.090B 0.00
Vaccinex (VCNX) United States $0.089B 0.00
Fortress Biotech (FBIO) United States $0.088B 0.00
Adocia (ADOCY) France $0.086B 0.00
Verastem (VSTM) United States $0.081B 0.00
ARAVIVE, INC (ARAV) United States $0.080B 0.00
Aduro Biotech (ADRO) United States $0.079B 0.00
Antibe Therapeutics (ATBPF) Canada $0.079B 0.00
Aquinox Pharmaceuticals (NLTX) Canada $0.078B 0.00
Checkpoint Therapeutics (CKPT) United States $0.077B 0.00
VTv Therapeutics (VTVT) United States $0.077B 0.00
Liquidia Technologies (LQDA) United States $0.074B 0.00
Idera Pharmaceuticals (IDRA) United States $0.073B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.071B 0.00
Mersana Therapeutics (MRSN) United States $0.071B 0.00
Curis (CRIS) United States $0.069B 0.00
Synlogic (SYBX) United States $0.066B 0.00
Prima BioMed (IMMP) Australia $0.065B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.064B 0.00
Catalyst Biosciences (CBIO) United States $0.064B 0.00
Selecta Biosciences (SELB) United States $0.063B 0.00
Orgenesis (ORGS) United States $0.058B 21.06
Catabasis Pharmaceuticals (CATB) United States $0.057B 0.00
Pluristem Therapeutics (PSTI) Israel $0.057B 0.00
Applied Genetic Technologies (AGTC) United States $0.056B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.055B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.054B 0.00
Arbutus Biopharma (ABUS) Canada $0.053B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.052B 0.00
AquaBounty Technologies (AQB) United States $0.051B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.051B 0.00
Vascular Biogenics (VBLT) Israel $0.047B 0.00
VistaGen Therapeutics (VTGN) United States $0.047B 0.00
Unum Therapeutics (UMRX) United States $0.045B 0.00
AIT Therapeutics (XAIR) United States $0.045B 0.00
NewLink Genetics (NLNK) United States $0.044B 0.00
Stellar Biotechnologies (EDSA) Canada $0.043B 0.00
Evogene (EVGN) Israel $0.042B 0.00
Ophthotech (ISEE) United States $0.041B 0.00
VIVUS (VVUS) United States $0.041B 0.00
AmpliPhi Biosciences (ARMP) United States $0.040B 0.00
Proteostasis Therapeutics (PTI) United States $0.040B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.040B 0.00
Organovo Holdings (ONVO) United States $0.039B 0.00
Oncobiologics (OTLK) United States $0.037B 0.00
Celsion (CLSN) United States $0.036B 0.00
Celldex Therapeutics (CLDX) United States $0.035B 0.00
Entera Bio (ENTX) Israel $0.034B 0.00
Fibrocell Science Inc (FCSC) United States $0.029B 9.90
Clearside Biomedical (CLSD) United States $0.028B 0.00
Alimera Sciences (ALIM) United States $0.028B 0.00
DiaMedica Therapeutics (DMAC) United States $0.026B 0.00
Protalix BioTherapeutics (PLX) Israel $0.026B 0.00
Aptevo Therapeutics (APVO) United States $0.026B 0.00
BioCardia (BCDA) United States $0.025B 0.00
Signal Genetics (MGEN) United States $0.024B 0.00
Caladrius Biosciences (CLBS) United States $0.024B 0.00
Aytu Bioscience (AYTU) United States $0.021B 0.00
Novogen (KZIA) Australia $0.020B 0.00
Apricus Biosciences (SEEL) United States $0.020B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.020B 0.00
Soligenix (SNGX) United States $0.018B 0.00
AEterna Zentaris (AEZS) United States $0.018B 0.00
CollPlant Holdings (CLGN) Israel $0.016B 0.00
Prana Biotechnology (ATHE) Australia $0.016B 0.00
Pulmatrix (PULM) United States $0.015B 0.00
TOCAGEN INC (TOCA) United States $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Cleveland BioLabs (CBLI) United States $0.011B 0.00
IBio (IBIO) United States $0.010B 0.00
TRACON Pharmaceuticals (TCON) United States $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Genetic Technologies (GENE) Australia $0.008B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.007B 0.00
TrovaGene (TROV) United States $0.006B 0.00
Titan Pharmaceuticals (TTNP) United States $0.006B 0.00
Bionano Genomics (BNGO) United States $0.006B 0.00
Advaxis (ADXS) United States $0.005B 0.00
BioPharmX (BPMX) United States $0.005B 0.00
Neuralstem (CUR) United States $0.003B 0.00